Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 3No longer available 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 12Carcinoma, Basal Cell 4Bowen's Disease 3Warts 1Uterine Cervical Dysplasia 1Skin Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

methyl 5-aminolevulinate 3Tomography, Optical Coherence 1SR-T100 1Photochemotherapy 1Myelin and Lymphocyte-Associated Proteolipid Proteins 1Lidocaine, Prilocaine Drug Combination 1Lidocaine 1Fluorouracil 1Epinephrine 1Anesthesia, Local 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Bowen's Disease × methyl 5-aminolevulinate × Clear all
NCT03909646 2025-05-06

BOWTIE

Maastricht University Medical Center

Phase 4 Completed
250 enrolled

Bowen's Disease

NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Galderma R&D

Phase 3 Completed
82 enrolled 20 charts
Dermatologic

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

NCT03012009 2018-01-25

Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial

University Hospital, Ghent

Phase NA Completed
16 enrolled

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡